Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. NVDA
6. ROIV
7. CRCL
8. V
9. HOOD
10. XOM

Go back to Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
(NASDAQ: MDCX) Delayed: 0.17 --0 (-0%)
Previous Close $0.17    52 Week High $ 
Open $0.17    52 Week Low $ 
Day High $0.18    P/E N/A 
Day Low $0.17    EPS $ 
Volume 1,671,957       

(NASDAQ: MDCX) Delayed: 0.17 --0 (-0%)
Previous Close $0.17    52 Week High $ 
Open $0.17    52 Week Low $ 
Day High $0.18    P/E N/A 
Day Low $0.17    EPS $ 
Volume 1,671,957